Download full-text PDF |
Source |
---|
Obstet Gynecol
January 2025
Riley Children's, the Division of Maternal-Fetal Medicine, Indiana University Health Fetal Center, and the Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana; the Division of Maternal-Fetal Medicine and Surgery, Fetal Care and Surgery Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; the Department of Obstetrics and Gynecology, Brown University Medical School, Providence, Rhode Island; the Fetal Medicine Unit, St George's Hospital, St George's University of London, London, United Kingdom; the Division of Maternal-Fetal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania; and the Division of Maternal-Fetal Medicine, The Ohio State University, Columbus, Ohio.
Objective: To investigate short-term maternal and neonatal outcomes in individuals with twin pregnancies and two prior cesarean deliveries who underwent trial of labor after cesarean (TOLAC).
Methods: A cross-sectional study of live-birth data was conducted between 2014 and 2021 in the United States. Individuals with more than two prior cesarean deliveries and multiple gestations higher than twins were excluded.
Obstet Gynecol
December 2024
Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, Illinois; the Department of Obstetrics, Gynecology & Reproductive Sciences, UPMC Magee-Womens Hospital, and the Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; and the Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, Rhode Island.
J Minim Invasive Gynecol
January 2025
Department of Obstetrics & Gynecology, Division of Gynecology University of Texas Southwestern Medical Center (Dr. Kho), Dallas, Texas.
Objective: To systematically review clinical and patient-reported outcomes after radiofrequency ablation (RFA) for the treatment of uterine fibroids.
Data Sources: We searched Medline, EMBASE, Cochrane Registry of Controlled Trials (CENTRAL) on September 8, 2023, and requested additional data from industry sources. We included published, peer-reviewed studies of patient-centered outcomes of RFA when used for symptomatic fibroids.
Matern Child Health J
October 2024
Department of Epidemiology, Brown University, Providence, RI, USA.
Objective: To compare reproductive history and postmenopausal health by birth status (preterm vs. full term) in a U.S.
View Article and Find Full Text PDFWMJ
July 2024
Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!